Cargando…
Chemoradiotherapy with Brachytherapy or Electron Therapy Boost for Locally Advanced Squamous Cell Carcinoma of the Anus—Reducing the Colostomy Rate
PURPOSE: The aim of this study is to determine overall survival, disease-specific survival and stoma-free survival after treatment of squamous cell carcinoma of the anus with chemoradiotherapy followed by brachytherapy or electron boost in a recent cohort of patients. METHODS: Fifty-two patients (me...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310557/ https://www.ncbi.nlm.nih.gov/pubmed/27412395 http://dx.doi.org/10.1007/s12029-016-9850-4 |
_version_ | 1782507893203927040 |
---|---|
author | Kent, C. Bessell, E. M. Scholefield, J. H. Chappell, S. Marsh, L. Mills, J. Sayers, I. |
author_facet | Kent, C. Bessell, E. M. Scholefield, J. H. Chappell, S. Marsh, L. Mills, J. Sayers, I. |
author_sort | Kent, C. |
collection | PubMed |
description | PURPOSE: The aim of this study is to determine overall survival, disease-specific survival and stoma-free survival after treatment of squamous cell carcinoma of the anus with chemoradiotherapy followed by brachytherapy or electron boost in a recent cohort of patients. METHODS: Fifty-two patients (median age 62 years) were treated with radical chemoradiotherapy (mitomycin C, infusional 5-fluorouracil concurrently with conformal radical radiotherapy 45 Gy in 25 fractions over 5 weeks) followed by a radiotherapy boost between 1 December 2000 and 30 April 2011. Follow-up was to 30 November 2014. Thirty-six patients received a boost (15–20 Gy) over 2 days with (192)Ir needle brachytherapy for anal canal tumours, and 16 patients received electron beam therapy (20 Gy in 10 fractions in 2 weeks) for anal margin tumours. A defunctioning stoma was only created prior to chemoradiotherapy for fistula or severe anal pain. RESULTS: The overall survival for the 36 patients treated with chemoradiotherapy followed by brachytherapy was 75 % (95 % CI, 61–89) at 5 years, the disease-specific survival was 91 % (95 % CI, 81–101 %), and the stoma-free survival was 97 % (95 % CI, 91–103 %) all at 5 years. For the 16 patients treated with an electron boost for anal margin tumours, the 5-year overall survival, disease-specific survival and stoma-free survival were 68 % (95 % CI, 44–92 %), 78 % (95 % CI, 56–100 %) and 80 % (95 % CI, 60–100 %), respectively. CONCLUSIONS: A very low stoma formation rate can be obtained with radical chemoradiotherapy followed by a brachytherapy boost for squamous cell carcinoma of the anal canal but not with an electron boost for anal margin tumours. |
format | Online Article Text |
id | pubmed-5310557 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-53105572017-02-28 Chemoradiotherapy with Brachytherapy or Electron Therapy Boost for Locally Advanced Squamous Cell Carcinoma of the Anus—Reducing the Colostomy Rate Kent, C. Bessell, E. M. Scholefield, J. H. Chappell, S. Marsh, L. Mills, J. Sayers, I. J Gastrointest Cancer Original Research PURPOSE: The aim of this study is to determine overall survival, disease-specific survival and stoma-free survival after treatment of squamous cell carcinoma of the anus with chemoradiotherapy followed by brachytherapy or electron boost in a recent cohort of patients. METHODS: Fifty-two patients (median age 62 years) were treated with radical chemoradiotherapy (mitomycin C, infusional 5-fluorouracil concurrently with conformal radical radiotherapy 45 Gy in 25 fractions over 5 weeks) followed by a radiotherapy boost between 1 December 2000 and 30 April 2011. Follow-up was to 30 November 2014. Thirty-six patients received a boost (15–20 Gy) over 2 days with (192)Ir needle brachytherapy for anal canal tumours, and 16 patients received electron beam therapy (20 Gy in 10 fractions in 2 weeks) for anal margin tumours. A defunctioning stoma was only created prior to chemoradiotherapy for fistula or severe anal pain. RESULTS: The overall survival for the 36 patients treated with chemoradiotherapy followed by brachytherapy was 75 % (95 % CI, 61–89) at 5 years, the disease-specific survival was 91 % (95 % CI, 81–101 %), and the stoma-free survival was 97 % (95 % CI, 91–103 %) all at 5 years. For the 16 patients treated with an electron boost for anal margin tumours, the 5-year overall survival, disease-specific survival and stoma-free survival were 68 % (95 % CI, 44–92 %), 78 % (95 % CI, 56–100 %) and 80 % (95 % CI, 60–100 %), respectively. CONCLUSIONS: A very low stoma formation rate can be obtained with radical chemoradiotherapy followed by a brachytherapy boost for squamous cell carcinoma of the anal canal but not with an electron boost for anal margin tumours. Springer US 2016-07-14 2017 /pmc/articles/PMC5310557/ /pubmed/27412395 http://dx.doi.org/10.1007/s12029-016-9850-4 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Research Kent, C. Bessell, E. M. Scholefield, J. H. Chappell, S. Marsh, L. Mills, J. Sayers, I. Chemoradiotherapy with Brachytherapy or Electron Therapy Boost for Locally Advanced Squamous Cell Carcinoma of the Anus—Reducing the Colostomy Rate |
title | Chemoradiotherapy with Brachytherapy or Electron Therapy Boost for Locally Advanced Squamous Cell Carcinoma of the Anus—Reducing the Colostomy Rate |
title_full | Chemoradiotherapy with Brachytherapy or Electron Therapy Boost for Locally Advanced Squamous Cell Carcinoma of the Anus—Reducing the Colostomy Rate |
title_fullStr | Chemoradiotherapy with Brachytherapy or Electron Therapy Boost for Locally Advanced Squamous Cell Carcinoma of the Anus—Reducing the Colostomy Rate |
title_full_unstemmed | Chemoradiotherapy with Brachytherapy or Electron Therapy Boost for Locally Advanced Squamous Cell Carcinoma of the Anus—Reducing the Colostomy Rate |
title_short | Chemoradiotherapy with Brachytherapy or Electron Therapy Boost for Locally Advanced Squamous Cell Carcinoma of the Anus—Reducing the Colostomy Rate |
title_sort | chemoradiotherapy with brachytherapy or electron therapy boost for locally advanced squamous cell carcinoma of the anus—reducing the colostomy rate |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310557/ https://www.ncbi.nlm.nih.gov/pubmed/27412395 http://dx.doi.org/10.1007/s12029-016-9850-4 |
work_keys_str_mv | AT kentc chemoradiotherapywithbrachytherapyorelectrontherapyboostforlocallyadvancedsquamouscellcarcinomaoftheanusreducingthecolostomyrate AT bessellem chemoradiotherapywithbrachytherapyorelectrontherapyboostforlocallyadvancedsquamouscellcarcinomaoftheanusreducingthecolostomyrate AT scholefieldjh chemoradiotherapywithbrachytherapyorelectrontherapyboostforlocallyadvancedsquamouscellcarcinomaoftheanusreducingthecolostomyrate AT chappells chemoradiotherapywithbrachytherapyorelectrontherapyboostforlocallyadvancedsquamouscellcarcinomaoftheanusreducingthecolostomyrate AT marshl chemoradiotherapywithbrachytherapyorelectrontherapyboostforlocallyadvancedsquamouscellcarcinomaoftheanusreducingthecolostomyrate AT millsj chemoradiotherapywithbrachytherapyorelectrontherapyboostforlocallyadvancedsquamouscellcarcinomaoftheanusreducingthecolostomyrate AT sayersi chemoradiotherapywithbrachytherapyorelectrontherapyboostforlocallyadvancedsquamouscellcarcinomaoftheanusreducingthecolostomyrate |